Circular RNAs (circRNAs) are widespread and diverse endogenous RNAs distinct from traditional linear RNAs, which may regulate gene expression in eukaryotes. However, the function of human circRNAs, including their potential role in lung cancer, remains largely unknown. We screened the circRNA circ0006916, which was evidently down-regulated in 16HBE-T cells (anti-benzopyrene-trans-7, 8-dihydrodiol-9, 10-epoxide-transformed human bronchial epithelial cells), and in A549 and H460 cell lines. Silencing of circ0006916, but not its parental gene homer scaffolding protein 1 (HOMER1), promoted cell proliferation via speeding up the cell cycle process rather than by inhibiting apoptosis; conversely, overexpression of circ0006916 had the opposite effect. Luciferase-screening assay indicated that circ0006916 bound to miR-522-3p and inhibited pleckstrin homology domain and leucine rich repeat protein phosphatase 1 (PHLPP1) activity. We also explored the effect of the RNA-binding protein trinucleotide repeat-containing 6A (TNRC6A) on circ0006916 production. Circ0006916 expression was decreased after silencing TNRC6A. TNRC6A bound to the intron regions around the circRNA-forming exons of circ0006916, as shown by RNA immunoprecipitation assay combined with sequencing analysis. The association of circ0006916 with TNRC6A was further verified by RNA pull-down assays. We then constructed a carrier and confirmed that TNRC6A binding to the flanked intron region of circ0006916 was necessary for generation of circ0006916. These results demonstrate that TNRC6A regulates the biogenesis of the circRNA circ0006916, which has a regulatory role in cell growth.
Introduction
Recent data released by the National Cancer Center showed that about 10 000 patients were diagnosed with cancer every day in China, with lung cancer being the leading cancer in terms of both morbidity and mortality. Benzene (a) pyrene is a component of cigarette smoke, and has been shown to induce skin, lung, gastrointestinal and other cancers (1, 2) , which is metabolized to antibenzopyrene-trans-7, 8-dihydrodiol-9, 10-epoxide (anti-BPDE) by P450 enzymes, rendering it carcinogenic. Further studies are needed to clarify the mechanisms responsible for lung cancer, especially in relation to anti-BPDE.
Numerous studies (3) have demonstrated an important role for non-coding RNAs in the progression of lung cancer, and both microRNAs (miRNAs) and long non-coding RNAs have been identified as important players in the process of lung carcinogenesis (4) (5) (6) . Circular RNAs (circRNAs) represent another class of non-coding RNAs that are widely expressed in mammals, and which may regulate gene expression in eukaryotes (7) . Unlike linear RNAs that are terminated by 5′ caps and 3′ tails, circRNAs form covalently closed-loop structures lacking 5′-3′ polarity and polyadenylated tails. Moreover, circRNAs are RNase R-resistant, making them more stable than linear RNAs (8) (9) (10) . Some circRNAs are expressed ubiquitously and are present at higher copy numbers (>10-fold) compared with their linear transcripts (11) . It is therefore important to understand the functions of circRNAs and their mechanisms in relation to tumorigenesis and tumor progression.
Most circRNAs are derived from the exons of protein-coding genes, with a few being derived from introns or intron fragments. Circ0006916 is circularized by four exons in the homer scaffolding protein 1 (HOMER1) gene, encoding a member of the Homer family of dendritic proteins, widely expressed in the brain (RPKM 8.6), thyroid (RPKM 5.8) and lung (RPKM 1.8) (12) . HOMER1 is involved in synapse formation, and circRNAs corresponding to the HOMER1 gene have been reported to be enriched in synaptic regions, implying that it might be involved in the regulation of neural development and physiological activity. The majority of circRNAs are also located in the cytoplasm (13) and show highly conserved sequences in different species, indicating that their formation is strictly regulated. Selective splicing is a key step in post-transcriptional RNA modification leading to the production of mature RNAs. In addition to linear RNAs, the process also produces lariat and Y-structure introns and circRNAs (9, 14) . The formation of some circRNAs has been reported to depend on RNA-binding proteins (RBPs), such as quaking in humans (15) and muscleblind in Drosophila S2 cells (16) . Variable splicing plays a critical role in receptor diversity, suggesting that splicing factors are likely to play an important role in the formation of circRNAs.
In this study, we analyzed the expression of circ0006916 and its parental gene HOMER1 in normal and lung cancer bronchial epithelial cells and in lung cancer tissues in relation to prognosis. We also examined the effect of circ0006916 on cell proliferation and the role of the RBP TNRC6A in the formation of circ0006916. The results of this study will enhance our understanding of the role of circRNAs and their regulatory mechanisms in malignant cells, and will support further studies of interactions between RBPs and circRNAs in relation to the upstream mechanisms of tumorigenesis, thus providing a new basis for cancer diagnosis and treatment.
Materials and methods

Cell culture and lung cancer tissue
Human bronchial epithelial 16HBE cells were donated by the State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, and the anti-BPDE-transformed human bronchial epithelial cell line, 16HBE-T, was generated in our laboratory (17) . 16HBE cells are immortalized human bronchial epithelial cells that are widely used for chemical induction testing (18) . Human A549 and H460 lung cancer cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). 293-T cells were donated by the Institute of Biology, Southern Medical University (Guangzhou, China).
Lung cancer tissue and adjacent tissue (≥5 cm from the cancer tissue) was collected from 49 patients undergoing radical or palliative resection for primary non-small cell lung cancer at the First Affiliated Hospital of Guangzhou Medical University, Department of Thoracic Surgery (Guangzhou, China) from October 2015 to January 2016. Patient consent and approval were obtained prior to the study. The surgically resected tissue was frozen in liquid nitrogen and subsequently stored at −80°C with the addition of RNAlater (Thermo Fisher Scientific, Carlsbad, CA). Tissue organizations were confirmed by a professional pathologist. This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University.
Extraction and quality analysis of total cellular RNA Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). The purity and concentration of the RNA were measured using a NanoDrop 1000 UV spectrophotometer (Nanodrop Technologies, Montchanin, DE). The integrity of the extracted RNA was detected by denaturing agarose gel electrophoresis.
Quantitative PCR
RNA was reverse transcribed into cDNA using a GoScript ™ Reverse Transcription System kit (Promega, Madison, WI). Target circRNAs were incubated with RNAse R (Epicentre, Madison, WI) 30 min at 37°C for (3 U enzyme per 1 µg of RNA) before reverse transcription. Real-time quantitative Polymerase Chain Reaction (qPCR) was performed using GoTaq® qPCR Master Mix (Promega) according to the manufacturer's protocol. The entire reaction was carried out on an Applied Biosystem 7500 RealTime PCR System (Applied Biosystem, Foster City, CA). β-actin, U6 or U1 were used as internal references, and all experiments were repeated at least three times. Unless stated otherwise, relative expression levels of all genes were calculated using the 2-ΔΔCt method, using gene primers (Supplementary Table 1 , available at Carcinogenesis Online) from Invitrogen.
RNA interference and overexpression experiments
Transfection assays were performed using Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions. Small interfering RNA (siRNA) and miRNA mimics were provided by GenePharma (Shanghai, China) (Supplementary Tables 2 and 3 , available at Carcinogenesis Online), and empty plasmids (pcircRNA1.1) and overexpression plasmids (pcircRNA1.2) were provided by BersinBio (Guangzhou, China) (Supplementary Figure 1 , available at Carcinogenesis Online).
5-Ethynyl-2′-deoxyuridine assay
16HBE, 16HBE-T, A549 and H460 cells were seeded in each well of 48-well plates for transfection with control siRNA/siCirc and empty vector/overexpression vector (oeCirc). After 48-h treatment, cell proliferation was detected by 5-ethynyl-2′-deoxyuridine (EdU) assay using a Cell-Light™ EdU DNA Cell Proliferation Kit (RiboBio, Shanghai, China) according to the manufacturer's instructions.
Cell cycle assay
Cells were seeded in six-well plates and cultured in serum-free medium for 24 h before transfection for 48 h. The cells were then harvested by trypsinization and washed twice with phosphate-buffered saline (PBS). Each sample was fixed overnight in 1 ml of 70% (v/v) ice-cold ethanol at 4°C, and then washed twice with 0.1% (v/v) Triton X-100 in PBS. The cells were stained with 20 μg/ml propidium iodide in PBS, treated with 200 μg/ ml RNase A in PBS at 37°C for 30 min and then analyzed immediately by flow cytometry (FACScan; Becton Dickinson, Franklin, NJ). The data were gated using FlowJo software (Tree Star Inc., Ashland, OR). 
Detection of cytoplasmic and nuclear localization
Cytoplasmic and nuclear fractions were isolated from 16HBE cells using a PARIS kit (Ambion, Austin, TX), as described previously (19) . Finally, cytoplasmic and nuclear RNAs were then converted to cDNA and analyzed by qPCR.
Dual-luciferase reporter assay
Dual fluorescein reporter gene detection was carried out using a Dual Luciferase Assay System kit (Promega) according to the manufacturer's instructions. 293-T cells were seeded into 24-well plates and cultured for 24 h to reach 60-70% confluency. Cells were then co-transfected with wild-type or mutant plasmids with miRNA mimics using Lipofectamine 2000 transfection reagent. After 48-h culture, passive lysis buffer cell lysate was added to each well and the supernatant was transferred to a new Eppendorf tube for subsequent detection. One hundred microliters of Luciferase Assay Reagent II was added to 20 μl of sample as the last step in each well of a 96-well plate, and the absorbance at 580 nm was measured using a microplate reader. Stop & Glo® Reagent (100 µl) was added to the same sample and the absorbance was measured at 460 nm.
CircRNA microarray analysis
Control siRNA and siTNR samples were homogenized in TRIzol reagent (Invitrogen) and the total RNA in each sample was quantified using a NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies). Sample preparation and microarray hybridization were performed based on Arraystar standard protocols (Arraystar Inc., Rockville). Briefly, total RNAs were digested with RNase R (Epicentre) to remove linear RNAs and enrich circular RNAs. The enriched circular RNAs were then amplified and transcribed into fluorescent cRNA utilizing random primers according to the Arraystar Super RNA Labeling protocol (Arraystar Inc.). The labeled cRNAs were hybridized onto the Arraystar Human circRNA Array (8 × 15 K, Arraystar). After washing the slides, the arrays were scanned with an Agilent G2505C Scanner (Agilent Technologies, CA) and the acquired array images were analyzed using Agilent Feature Extraction software (version 11.0.1.1). Quantile normalization and subsequent data processing were performed using the R software package.
RBP immunoprecipitation assay
For the RBP immunoprecipitation (RIP) assay, 16HBE cells were harvested by trypsinization and sheared mechanically using a homogenizer. Biotinlabeled TNRC6A antibodies were added to the cell extract and incubated overnight at 4°C, followed by the addition of streptavidin-coated magnetic beads and incubation for a further 4 h at 4°C. The magnetic beads were pelleted, washed and re-suspended in 1 ml TRIzol. The isolated RNA was dissolved in 10-20 μl of Diethy pyrocarbonate and stored at −80°C.
Sequencing and analysis of RIP product
After RIP product quality inspection, cDNA was prepared and amplified using an Ovation RNA-Seq System V2 kit (NuGEN, San Carlos, CA) following the manufacturer's instructions. The amplified cDNA was fragmented using a Bioruptor (Diagenode, Belgium), followed by ligation of adaptors using a TruSeq ChiP Sample Preparation kit (Illumina, San Diego, CA). DNA fragments of 300-350 bp were isolated from a 2.5% agarose gel and subjected to 17 cycles of PCR amplification. The quality of the cDNA libraries were analyzed using an Agilent Bioanalyzer 2100 (Agilent Technologies), sequenced using an Illumina HiSeq 2500 instrument (Illumina) and deposited in GSE92632 (GEO database ID number). We extracted the upstream and downstream intron sequences of circ0006916 in reverse cleavage sites and carried out intron alignments using the parameters '-task blastn -word_size 11'. Finally, a series of repeat sequences and upstream and downstream reverse complementary sequences were obtained.
RNA pull-down assay
In this study, the interaction between RBP TNRC6A and the circRNA introns was detected using the BersinBio TM RNA pull-down Kit. Based on the sequence of the circ0006916 introns, we designed and synthesized of biotin-labeled specific pull-down probe. Biotin-labeled RNA probe (1 µg) was denatured to form the secondary structure, and 40 μl magnetic beads were then added to prepare a probe-magnetic bead complex. 16HBE cells were collected and whole cell proteins were extracted for RNA pull-down assay. After binding of the RBPs to the RNA, the samples were washed and the RBP complexes were eluted. RNA pull down was carried out according to the kit instructions. The samples were collected and 15 μl of each sample was subjected to PAGE.
Vector construction
We cloned two reverse complementary sequence pairs and two short interspersed nuclear elements (SINEs) into the pcircRNA 1.2 expression vector through the BamHI and EcoRI 2 cleavage sites, named p1-p4.
Protein immunoblotting
Total protein extraction kit (KeyGen Biotech, Nanjing, China) was used to extract total protein. Procedures were followed according to the kit manual. The proteins separated on 10% SDS-PAGE gels, concentrated on 5% SDS-PAGE gels and then blotted on polyvinylidene difluoride membranes (Merck Millipore, Billerica, MA). Following hybridization with a monoclonal antibody at 4°C overnight, the membranes were incubated with a secondary antibody at room temperature for 1 h. Finally, the data normalized by β-actin were scanned and analyzed using an ODYSSEY double color infrared laser imaging system (Li-Cor, Lincoln, NE). The primary antibodies used in this study were as follows: anti-TNRC6A (dilution 1:200, Sigma, St Louis, MO), anti-PHLPP1 (dilution 1:2000, Affinity, Affinity Biosciences, Cincinnati, OH) and anti-β-actin (dilution 1:10 000, Abcam, Cambridge, UK).
Statistical analysis
Each experiment was subjected to at least three biological replicates, and the data were expressed as mean ± standard deviation. Differences between two groups of data were analyzed by independent sample t-tests, and differences among multiple groups were compared by ANOVA. A P value <0.05 indicated a significant difference, and a P value < 0.01 was regarded as highly significant.
Results
Circ0006916 was down-regulated in malignantly transformed cells and in lung cancer cells and tissues
We selected 19 circRNAs (circ0006916, circ0008035, circ0058916, circ0071681, circ0049271, circ0005139,circ0035189, circ0007386, circ0034168, circ0000437, circ0030042, circ0063158, circ0089490, circ0079557, circ0001081, circ0009021, circ0000462, circ0001095 and circ0046215) related to lung cancer in the circBase database, and in A549 cells from the literature (20) , and detected their expression levels in normal bronchial epithelial cells (16HBE), anti-BPDE malignantly transformed cells (16HBE-T) and lung cancer cells (A549 and H460) by qPCR. Expression levels of six circRNAs were consistent and down-regulated in 16HBE-T, A549 and H460 cells ( Figure 1A ) compared with 16HBE cells. Repeated verification revealed that circ0006916 expression was relatively stable and abnormally low, with expression levels of 1.1 ± 0.3%, 6.7 ± 5.1% and 1.5 ± 0.3% in 16HBE-T, A549 and H460 cells, respectively, compared with 16HBE cells. Circ0006916 was thus selected as a candidate gene for further study. Similar to the situations in the cell lines, circ0006916 expression levels were also downregulated in 65.3% (32/49) of lung cancer tissues, compared with the paired adjacent normal tissues ( Figure 1B) , prompting us to investigate the function of circ0006916. The first four exons of HOMER1 were obtained from circ0006916 by circular shearing and HOMER1 mRNA was transcribed by linear splicing.
We further explored the function of circ0006916 by constructing interfering (siCirc) ( Figure 1C ) and overexpressing (oeCirc) (Supplementary Figure 1 , available at Carcinogenesis Online) systems, and then detecting expression levels of both circ0006916 and mRNA of its parebtal gene HOMER1 by qPCR. Circ0006916 expression was significantly down-or up-regulated compared with the control after transfection with siCirc or oeCirc plasmids, respectively, in all four cell lines (16HBE, 16HBE-T, A549 and H460), while HOMER1 mRNA expression was unchanged ( Figure 1D ). As expected, the siRNA and overexpression vectors directed against the back-splice sequence only influenced the circular transcript and had no effect on the expression of the linear species. The linear HOMER1 gene did not function in our siCirc and oeCirc systems.
Circ0006916 inhibited cell proliferation by influencing cell cycle progression but not apoptosis
Cell proliferation in 16HBE cells was enhanced by knockdown and impaired by overexpression of circ0006916, as shown by subsequent EdU incorporation assay (Figure 2A and B) . Similar results were obtained in 16HBE-T, A549 and H460 cells. We determined if circ0006916 affected cell growth by regulating the cell cycle and/or cell apoptosis by analyzing the proportions of cell populations in each cell cycle phase (G0/G1, S, G2/M and S+G2/M) using flow cytometric analysis. Circ0006916-knockdown cells had a significantly smaller G0/G1 population compared with control cells in all the cell lines, while overexpression of circ0006916 resulted in accumulation of cells in G0/ G1 phase ( Figure 3A and B), suggesting that circ0006916 was involved in the G1/S transition. We determined if the effect of circ0006916 on cell proliferation in 16HBE cells was mediated via cell apoptosis. There was no significant difference in cell apoptosis rates between the control siRNA/siCirc and empty vector/ oeCirc cells ( Figure 3C and D), demonstrating that circ0006916 inhibited cell proliferation by influencing cell cycle progression rather than via apoptosis in vitro.
Circ0006916 served as a sponge for miR-522-3p
We determined the cytoplasmic/nuclear distribution of circ0006916 to help elucidate its underlying mechanisms. We separated the cytoplasmic and nuclear fractions of 16HBE cells and detected the cytoplasmic/nuclear ratios of circ0006916. Circ0006916 was mainly detected in the cytoplasm ( Figure 4A ), suggesting that it may play a role during post-transcriptional regulation. Given that circRNA has been shown to act as a miRNA sponge, we investigated the ability of circ0006916 to bind to miRNAs identified using online software (http://regrna.mbc.nctu. edu.tw/index1.php, which identified 117 miRNAs that could possibly bind to circ0006916. Combined with the five miRNA response element data for circ0006916 in the circRNA microarray on siTNR, we selected five miRNAs (miR-103a-2-5p, miR-145-3p, miR-148-5p, miR-522-3p and miR-138-5p) that were highly expressed in A549 cells by qPCR ( Figure 4B ). We constructed a wild-type circ0006916 luciferase reporter vector (pmirGLOcirc0006916) containing the full-length sequence of circ0006916, and detected the luciferase intensity when miR-522-3p mimics were transfected in 293-T cells, compared with the miRNA negative control (miR-NC) ( Figure 4C ). MiR-522-3p significantly inhibited the luciferase activity of the wild-type reporter of circ0006916 (>60%). We confirmed a direct interaction between circ0006916 and miR-522-3p by establishing circ0006916 mutations. Information on the vector used in the luciferase reporter assays is shown in Figure 4D . Co-transfection of circ0006916-mutant luciferase reporters and miR-522-3p mimics into 293-T cells recovered luciferase intensity by >40% ( Figure 4E ). MiR-522-3p remarkably suppressed the luciferase activity of the reporter gene with the wild-type pmirGIO-circ0006916 construct, but not with the mutant pmirGIO-circ0006916 construct, in 293-T cells, indicating that miR-522-3p directly combined with circ0006916. PHLPP1 has been reported to be highly correlated with regulation of the cell cycle and cell proliferation, and is a direct target of miR-522-3p, as previously verified by luciferase assays (21) . We showed that the mRNA expression levels of PHLPP1 were significantly lower in 16HBE-T, A549 and H460 cells compared with 16HBE cells, consistent with the results for circ0006916 ( Figure 4F ). In addition, PHLPP1 was down-regulated by circ0006916-knockdown and up-regulated by circ0006916 overexpression at the mRNA and protein levels in 16HBE-T, A549 and H460 cells (Figure 4G-I ). Circ0006916 thus functions in cell proliferation and the cell cycle by acting as a sponge for miR-522-3p, and may compete with PHLPP1 for miR-522-3p.
RBP TNRC6A affected circ0006916 generation
CircRNA generation is related to variable splicing. We therefore screened RBPs associated with variable splicing and tumorigenesis, including TNRC6A, heterogeneous nuclear ribonucleoprotein L like, pumilio RNA-binding family member 2, KH RNA-binding domain-containing, signal transduction associated 1 and argonaute 4 in 16HBE and 16HBE-T cells using qPCR. Figure 4 , available at Carcinogenesis Online). We determined if TNRC6A could affect circRNA production by constructing a loss-of-function system. Four siRNA (siTNR1-4) sequences were designed for TNRC6A and their interference efficiencies in 16HBE cells were detected by qPCR ( Figure 5D ). siTNR-1 and siTNR-4 had greater effects at a concentration of 50 nM compared with other siRNAs (siTNR-2 or siTNR-3) and other concentrations (30 or 80 nM). We also detected TNRC6A protein levels using western blot assays and showed that TNRC6A protein expression was decreased by siRNA treatment ( Figure 5E ). We detected the effects of siTNR on circRNA expression profiles using microarray technology. Scatter and volcano plots showed differences in circRNA expression between the control siRNA and siTNR samples ( Figure 5F ). A total of 396 differentially expressed circRNAs with foldchanges >1.5 were identified, including 202 circRNAs that were up-regulated and 194 that were down-regulated (Supplementary  Table 4 , available at Carcinogenesis Online). Microarray analysis showed that circ0006916 expression was also reduced after silencing TNRC6A. We verified the microarray results by qPCR, which confirmed that circ0006916 expression was down-regulated in siTNR samples ( Figure 5G ). TNRC6A was thus required for the efficient formation of circ0006916. We examined the expression of HOMER1 mRNA to see if the decreased expression of circ0006916 in siTNR-treated cells was a consequence of active regulation of circ0006916 rather than of its parent gene, HOMER1. HOMER1 expression in 16HBE cells was unaffected by siTNR, indicating that circ0006916 down-regulation was not due to down-regulation of its parental gene ( Figure 5H ).
TNRC6A bound to the flanked intron regions of circ0006916 to promote its production
We then further validated the direct interaction between TNRC6A and circ0006916 pre-mRNA using TNRC6A-RIP assays in 16HBE cells. We designed five pairs of primers (H-1-H-5) of the intron subdomain (Supplementary Table 5 , available at Carcinogenesis Online) in circ0006916 pre-mRNA and quantified TNRC6A occupancy within the introns adjacent to the circRNAforming exons by qPCR ( Figure 6A ). TNRC6A tended to bind to the intron-adjacent sites H-1 and H-5 more than to the other intron-adjacent sites and the circRNA itself ( Figure 6B ). We performed high-throughput sequencing of the RIP products to determine if the TNRC6A-binding sites in the introns flanking the circRNA-forming exons of circ0006916 were necessary for circRNA biogenesis. Analysis of the upstream and downstream flanking introns of circ0006916 showed 137 SINEs, 37 long interspersed nuclear elements, six long terminal repeat elements, 26 DNA elements, one small RNA, 20 simple repeats and 1 low complexity, and also revealed 26 reverse complementary sequence pairs, respectively, located upstream and Table 6 , available at Carcinogenesis Online) were found and four biotin-labeled probes were constructed. Link sequences needed to be added between the upstream and downstream reverse complementary sequences. We therefore captured the RNA complexes associated with the intron fragment probes by RNA pull-down assays. The intron fragments could pull-down TNRC6A, as shown by western blot analysis, which confirmed the specificity of the interaction between circ0006916 and TNRC6A in 16HBE cells ( Figure 6C ). Among these, first and fourth probe combined most effectively with TNRC6A. Two reverse complementary sequence pairs and two SINEs were then cloned into the pcircRNA 1.2 overexpression vector, and named p1-p4 ( Figure 6D ). The expected circRNA production in 16HBE, 16HBE-T, A549 and H460 cells was detected by qPCR after transfection with the expression vectors. Circularization was increased to varying degrees, indicating that the expression vectors, particularly p1 and p4 expression, affected cyclization ( Figure 6E ). To verify the fact that circRNA production was dependent on TNRC6A, siRNAmediated TNRC6A knockdown in cells co-transfected with p1-p4 largely abrogated the production of circular but not linear products, consistent with a dependence of circRNA production on TNRC6A ( Figure 6F and G) . Overall, these results indicate that TNRC6A promoted circRNA production from genes with TNRC6A-binding sites located appropriately within the introns. 
Discussion
Lung cancer is one of the main cancers threatening human health and survival, with the fastest growing incidence and mortality. Previous studies by our group suggested that noncoding RNAs play an important role in the progress of lung cancer (19, 22) . Numerous circRNAs are now also known to be abundant and specifically expressed in various cells and tissues (16) , suggesting that they serve a specific function. CircRNAs can be verified by performing qPCR on RNase R-treated RNA using divergent primers that amplify across the splice junction unique to the circular form of RNA. In the current study, we showed that circ0006916 had abnormally low expression levels in 16HBE-T, A549 and H460 cells. Using RNA interference and overexpression, we also found that circ0006916 could act as a tumor suppressor gene by affecting the cell cycle distribution and inhibiting cell proliferation. Other previous studies showed that many noncoding RNAs were highly effective competitive endogenous RNAs, such as ciRS-7/CDR1as, which acted as a sponge for miR-7 in mammalian cells, and a circRNA from the testes-specific Sry gene, which acted as a sponge for miR-138 (23, 24) . We demonstrated that circ0006916 was mainly located in the cytoplasm, suggesting that it was likely to function in post-transcriptional regulation. Combined microassay and RegRNA software prediction analysis predicted the existence of multiple miRNA-binding sites in the circ0006916 sequence, indicating that circ0006916 might also function as a miRNA sponge. We verified five of these miRNAs via dual-luciferase reporter assays and confirmed that circ0006916 bound to miR-522-3p. Furthermore, PHLPP1 has been reported as a direct target of mir-522-3p, via a possible mechanism involving cell cycle inhibition (25) (26) (27) (28) (29) . Knockdown of circ0006916 resulted in decreased expression of PHLPP1 and in turn the expression of PHLPP1 increased, suggesting that circ0006916 may play a role in lung cancer progression and exert regulatory functions by binding to miR-522-3p. However, the difficulty of designing an oeCirc at the back-splice junction of circRNA meant that we were unable to elucidate the specific mechanism whereby circ0006916 competes with PHLPP1 in combination with miR-522-3p, thus regulating the cell cycle and cell proliferation. Further more effective, accurate and specific studies are thus needed to clarify these mechanisms. Previous studies have revealed that circRNA generation is related to variable splicing, and abnormal splicing has been shown to be involved in lung carcinogenesis; however, the relationships among circRNAs, variable splicing and lung cancer remain unknown (16, 30) . Previous studies suggested that RBPs play an important role in the cyclization of circRNAs (15) , and numerous RBP genes have been associated with variable splicing and tumors (30, 31) . Using RBP loss-of-function and microassay technology, we showed that TNRC6A was essential for enhanced production of circ0006916, while silencing of TNRC6A was sufficient to reduce formation of circ0006916 but not HOMER1 mRNA (32, 33) .
Several studies have reported on the regulation of circRNA expression levels (34, 35) . For example, many circRNAs are flanked by structured introns that may be paired to each other to form dsRNA across circularizing exons, but the dsRNA structure is not required for backsplicing. The normal 5'ss is required for backsplicing, and mutations in the consensus 5'ss disrupted circRNA production (36) . We demonstrated the important role of TNRC6A in the generation of circ0006916 by selecting RNA that interacted with TNRC6A by RIP and sequencing its products. Sequencing revealed the reverse complementary sequence (33) and ALU elements that bind to TNRC6A in the flanked subdomain of circ0006916. By constructing a vector containing the binding site, we confirmed that TNRC6A promoted circ0006916 generation by binding to recognition elements in the flanking intron in the vicinity of the circRNA-forming splice sites. Co-transfection with siTNR down-regulated the expression of circ0006916, confirming dependence of circRNA production on TNRC6A. We also constructed a vector to detect the impact of TNRC6A-binding elements in the flanking intron of circ0006916 on the generation of circ0006916. Examining the effects of mutations in these sequences on the expression of circRNA in future studies will help to clarify the importance of this interaction.
In conclusion, we demonstrated an important role for circ0006916 in anti-BPDE-induced carcinogenesis. Circ0006916 could act as a microRNA sponge and compete with mRNA to bind to miRNA, thereby regulating mRNA expression. The RBP TNRC6A enhances the production of circ0006916, thus furthering our understanding of the upstream mechanisms of tumorigenesis. Overall, these findings provide a new basis for the generation and role of circRNA in anti-BPDE-induced carcinogenesis.
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